Glenn Dranoff

43.8k total citations · 11 hit papers
188 papers, 25.4k citations indexed

About

Glenn Dranoff is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Glenn Dranoff has authored 188 papers receiving a total of 25.4k indexed citations (citations by other indexed papers that have themselves been cited), including 151 papers in Immunology, 103 papers in Oncology and 40 papers in Molecular Biology. Recurrent topics in Glenn Dranoff's work include Immunotherapy and Immune Responses (113 papers), Immune Cell Function and Interaction (60 papers) and Cancer Immunotherapy and Biomarkers (55 papers). Glenn Dranoff is often cited by papers focused on Immunotherapy and Immune Responses (113 papers), Immune Cell Function and Interaction (60 papers) and Cancer Immunotherapy and Biomarkers (55 papers). Glenn Dranoff collaborates with scholars based in United States, Switzerland and Japan. Glenn Dranoff's co-authors include George Coukos, Ira Mellman, Matthew W. Vanneman, Michael Dougan, F. Stephen Hodi, David Mooney, Richard C. Mulligan, Martín C. Mihm, Gordon J. Freeman and Arlene H. Sharpe and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Glenn Dranoff

188 papers receiving 25.0k citations

Hit Papers

Cancer immunotherapy comes of age 1994 2026 2004 2015 2011 2012 2004 2003 2017 1000 2.0k 3.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Cancer immunotherapy comes of age
    2011 3.1k citations Glenn Dranoff et al. profile →
  2. Combining immunotherapy and targeted therapies in cancer treatment
    2012 1.2k citations Glenn Dranoff et al. profile →
  3. Cytokines in cancer pathogenesis and cancer therapy
    2004 1.2k citations Glenn Dranoff profile →
  4. Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients
    2003 778 citations F. Stephen Hodi, Martín C. Mihm et al. profile →
  5. Prospects for combining targeted and conventional cancer therapy with immunotherapy
    2017 766 citations Glenn Dranoff et al. profile →
  6. Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules
    1997 738 citations Glenn Dranoff et al. profile →
  7. Involvement of Granulocyte-Macrophage Colony-Stimulating Factor in Pulmonary Homeostasis
    1994 694 citations Glenn Dranoff et al. profile →
  8. Coinhibitory Pathways in Immunotherapy for Cancer
    2016 670 citations Gordon J. Freeman, Glenn Dranoff et al. profile →
  9. TIM-1 and TIM-4 Glycoproteins Bind Phosphatidylserine and Mediate Uptake of Apoptotic Cells
    2007 523 citations Masahisa Jinushi, Arlene H. Sharpe et al. profile →
  10. Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients
    2008 488 citations F. Stephen Hodi, Christine Canning et al. profile →
  11. Injectable, spontaneously assembling, inorganic scaffolds modulate immune cells in vivo and increase vaccine efficacy
    2014 457 citations Sarah A. Lewin, Caroline S. Verbeke et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Glenn Dranoff United States 76 15.7k 12.4k 6.7k 2.5k 2.3k 188 25.4k
Ignacio Melero Spain 88 16.8k 1.1× 15.8k 1.3× 6.6k 1.0× 3.0k 1.2× 2.1k 0.9× 396 28.2k
Matthew F. Krummel United States 65 17.8k 1.1× 11.2k 0.9× 6.4k 1.0× 2.9k 1.2× 2.0k 0.9× 162 27.4k
Robert H. Vonderheide United States 74 14.2k 0.9× 15.2k 1.2× 6.9k 1.0× 2.4k 1.0× 1.6k 0.7× 224 25.0k
Ton N. Schumacher Netherlands 83 22.7k 1.4× 17.9k 1.4× 9.7k 1.5× 2.4k 1.0× 1.6k 0.7× 311 34.3k
Gosse J. Adema Netherlands 86 16.8k 1.1× 7.2k 0.6× 9.4k 1.4× 1.2k 0.5× 1.6k 0.7× 313 26.0k
Yang‐Xin Fu United States 99 22.5k 1.4× 14.2k 1.1× 9.8k 1.5× 3.5k 1.4× 2.3k 1.0× 377 37.9k
Vincenzo Bronte Italy 78 21.1k 1.3× 11.2k 0.9× 6.7k 1.0× 1.6k 0.6× 1.7k 0.7× 183 29.0k
Thomas F. Gajewski United States 82 20.9k 1.3× 19.8k 1.6× 11.9k 1.8× 3.1k 1.3× 1.2k 0.5× 321 36.1k
Kai W. Wucherpfennig United States 81 14.5k 0.9× 7.0k 0.6× 6.4k 1.0× 2.6k 1.0× 981 0.4× 203 23.9k
Dario A.A. Vignali United States 85 22.9k 1.5× 12.2k 1.0× 7.0k 1.0× 1.6k 0.6× 952 0.4× 242 33.4k

Countries citing papers authored by Glenn Dranoff

Since Specialization
Citations

This map shows the geographic impact of Glenn Dranoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Glenn Dranoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Glenn Dranoff more than expected).

Fields of papers citing papers by Glenn Dranoff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Glenn Dranoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Glenn Dranoff. The network helps show where Glenn Dranoff may publish in the future.

Co-authorship network of co-authors of Glenn Dranoff

This figure shows the co-authorship network connecting the top 25 collaborators of Glenn Dranoff. A scholar is included among the top collaborators of Glenn Dranoff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Glenn Dranoff. Glenn Dranoff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Siqi, Brian Granda, Rajiv Chopra, et al.. (2020). A CRISPR Screen Reveals Resistance Mechanisms to CD3-Bispecific Antibody Therapy. Cancer Immunology Research. 9(1). 34–49. 14 indexed citations
2.
Goyal, Girija, Karrie Wong, Christopher J. Nirschl, et al.. (2018). PPARγ Contributes to Immunity Induced by Cancer Cell Vaccines That Secrete GM-CSF. Cancer Immunology Research. 6(6). 723–732. 27 indexed citations
3.
Zhou, Jun, Kathleen M. Mahoney, Anita Giobbie‐Hurder, et al.. (2017). Soluble PD-L1 as a Biomarker in Malignant Melanoma Treated with Checkpoint Blockade. Cancer Immunology Research. 5(6). 480–492. 284 indexed citations
4.
Wu, Xinqi, Jingjing Li, Xiaoyun Liao, et al.. (2017). Combined Anti-VEGF and Anti–CTLA-4 Therapy Elicits Humoral Immunity to Galectin-1 Which Is Associated with Favorable Clinical Outcomes. Cancer Immunology Research. 5(6). 446–454. 58 indexed citations
5.
Exley, Mark A., Phillip Friedlander, Nadia Alatrakchi, et al.. (2017). Adoptive Transfer of Invariant NKT Cells as Immunotherapy for Advanced Melanoma: A Phase I Clinical Trial. Clinical Cancer Research. 23(14). 3510–3519. 126 indexed citations
6.
Clancy‐Thompson, Eleanor, Lestat R. Ali, Patrick T. Bruck, et al.. (2017). IAP Antagonists Enhance Cytokine Production from Mouse and Human iNKT Cells. Cancer Immunology Research. 6(1). 25–35. 24 indexed citations
7.
Ali, Omar A., Sarah A. Lewin, Glenn Dranoff, & David Mooney. (2016). Vaccines Combined with Immune Checkpoint Antibodies Promote Cytotoxic T-cell Activity and Tumor Eradication. Cancer Immunology Research. 4(2). 95–100. 124 indexed citations
8.
Curry, William T., Matthias Piesche, Tetsuro Sasada, et al.. (2016). Vaccination with Irradiated Autologous Tumor Cells Mixed with Irradiated GM-K562 Cells Stimulates Antitumor Immunity and T Lymphocyte Activation in Patients with Recurrent Malignant Glioma. Clinical Cancer Research. 22(12). 2885–2896. 45 indexed citations
9.
Sridharan, Vishwajith, Evisa Gjini, Xiaoyun Liao, et al.. (2016). Immune Profiling of Adenoid Cystic Carcinoma: PD-L2 Expression and Associations with Tumor-Infiltrating Lymphocytes. Cancer Immunology Research. 4(8). 679–687. 77 indexed citations
10.
Reardon, David A., Prafulla C. Gokhale, Sarah R. Klein, et al.. (2015). Glioblastoma Eradication Following Immune Checkpoint Blockade in an Orthotopic, Immunocompetent Model. Cancer Immunology Research. 4(2). 124–135. 302 indexed citations
11.
Piesche, Matthias, Vincent T. Ho, Haesook Kim, et al.. (2014). Angiogenic Cytokines Are Antibody Targets During Graft-versus-Leukemia Reactions. Clinical Cancer Research. 21(5). 1010–1018. 10 indexed citations
12.
Selvarajah, Shamini, Saumyadipta Pyne, Eleanor Y. Chen, et al.. (2014). High-Resolution Array CGH and Gene Expression Profiling of Alveolar Soft Part Sarcoma. Clinical Cancer Research. 20(6). 1521–1530. 25 indexed citations
13.
Ali, Omar A., Caroline S. Verbeke, Chris Johnson, et al.. (2014). Identification of Immune Factors Regulating Antitumor Immunity Using Polymeric Vaccines with Multiple Adjuvants. Cancer Research. 74(6). 1670–1681. 78 indexed citations
14.
Righi, Elda, Satoshi Kashiwagi, J. P. Yuan, et al.. (2011). CXCL12/CXCR4 Blockade Induces Multimodal Antitumor Effects That Prolong Survival in an Immunocompetent Mouse Model of Ovarian Cancer. Cancer Research. 71(16). 5522–5534. 191 indexed citations
15.
Schoenfeld, Jonathan D., Masahisa Jinushi, Yukoh Nakazaki, et al.. (2010). Active Immunotherapy Induces Antibody Responses That Target Tumor Angiogenesis. Cancer Research. 70(24). 10150–10160. 64 indexed citations
16.
Wong, Kwok‐Kin, Tyler Jacks, & Glenn Dranoff. (2010). NF-κB Fans the Flames of Lung Carcinogenesis. Cancer Prevention Research. 3(4). 403–405. 25 indexed citations
17.
Ogino, Shuji, Katsuhiko Nosho, Natsumi Irahara, et al.. (2009). Lymphocytic Reaction to Colorectal Cancer Is Associated with Longer Survival, Independent of Lymph Node Count, Microsatellite Instability, and CpG Island Methylator Phenotype. Clinical Cancer Research. 15(20). 6412–6420. 308 indexed citations
18.
Lin, William M., Alissa C. Baker, Rameen Beroukhim, et al.. (2008). Modeling Genomic Diversity and Tumor Dependency in Malignant Melanoma. Cancer Research. 68(3). 664–673. 215 indexed citations
19.
Jinushi, Masahisa, Yukoh Nakazaki, Daniel R. Carrasco, et al.. (2008). Milk Fat Globule EGF-8 Promotes Melanoma Progression through Coordinated Akt and Twist Signaling in the Tumor Microenvironment. Cancer Research. 68(21). 8889–8898. 95 indexed citations
20.
Dranoff, Glenn. (2003). Coordinated tumor immunity. Journal of Clinical Investigation. 111(8). 1116–1118. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ignacio Melero Breakdown of academic impact, for papers by Matthew F. Krummel Breakdown of academic impact, for papers by Robert H. Vonderheide Breakdown of academic impact, for papers by Ton N. Schumacher Breakdown of academic impact, for papers by Gosse J. Adema Breakdown of academic impact, for papers by Yang‐Xin Fu Breakdown of academic impact, for papers by Vincenzo Bronte Breakdown of academic impact, for papers by Thomas F. Gajewski Breakdown of academic impact, for papers by Kai W. Wucherpfennig Breakdown of academic impact, for papers by Dario A.A. Vignali
Rankless by CCL
2026